Literature DB >> 14557184

Estimates of incidence rates with longitudinal claims data.

Frank A Sloan1, Derek S Brown, Emily S Carlisle, Jan Ostermann, Paul P Lee.   

Abstract

OBJECTIVE: To estimate incidence rates of the 3 major chronic eye diseases--diabetic retinopathy (DR), glaucoma, and age-related macular degeneration (ARMD)--by using longitudinal claims data from Medicare.
METHODS: Longitudinal cases were ascertained by using a national probability sample of Medicare beneficiaries aged 65 years and older in 1991 who initially had none of the eye diseases documented. After adjusting for death and enrollment in a health maintenance organization, claims filed by optometrists or ophthalmologists with an International Classification of Diseases, Ninth Revision, Clinical Modification code for all forms of DR, glaucoma, and ARMD were used to indicate diagnosis.
RESULTS: Annual incidence rates for the 3 conditions after the first year of observation ranged from 14.3% to 17.7% (higher earlier) across an 8-year longitudinal follow-up. Incidence rates among those with diabetes mellitus for any form of DR varied between 3.8% and 6.5%, while those for glaucoma varied between 4.6% and 7.8% and those for ARMD varied between 7.5% and 9.3%.
CONCLUSIONS: Longitudinal claims data after the first year provide relatively stable estimates of incidence rates on an annual basis. These estimates are comparable with those of the few population-based studies available.

Entities:  

Mesh:

Year:  2003        PMID: 14557184     DOI: 10.1001/archopht.121.10.1462

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  20 in total

1.  Estimation of disease incidence in claims data dependent on the length of follow-up: a methodological approach.

Authors:  Sascha Abbas; Peter Ihle; Ingrid Köster; Ingrid Schubert
Journal:  Health Serv Res       Date:  2012-04       Impact factor: 3.402

2.  Effect of Prior Anti-VEGF Injections on the Risk of Retained Lens Fragments and Endophthalmitis after Cataract Surgery in the Elderly.

Authors:  Paul Hahn; Arseniy P Yashkin; Frank A Sloan
Journal:  Ophthalmology       Date:  2015-08-13       Impact factor: 12.079

3.  Age patterns of incidence of geriatric disease in the U.S. elderly population: Medicare-based analysis.

Authors:  Igor Akushevich; Julia Kravchenko; Svetlana Ukraintseva; Konstantin Arbeev; Anatoliy I Yashin
Journal:  J Am Geriatr Soc       Date:  2012-01-27       Impact factor: 5.562

4.  What age trajectories of cumulative deficits and medical costs tell us about individual aging and mortality risk: Findings from the NLTCS-Medicare data.

Authors:  Anatoli I Yashin; Konstantin G Arbeev; Alexander Kulminski; Igor Akushevich; Lucy Akushevich; Svetlana V Ukraintseva
Journal:  Mech Ageing Dev       Date:  2008-02-01       Impact factor: 5.432

5.  Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients: a Canadian population-based analysis.

Authors:  Michael Iskedjian; David W Covert; John H Walker
Journal:  Patient       Date:  2011       Impact factor: 3.883

6.  Six-year retrospective follow-up study of safe screening intervals for sight-threatening retinopathy in patients with diabetes mellitus.

Authors:  Enrique Soto-Pedre; Maria Concepcion Hernaez-Ortega; José Antonio Vázquez
Journal:  J Diabetes Sci Technol       Date:  2009-07-01

Review 7.  Use of health care claims data to study patients with ophthalmologic conditions.

Authors:  Joshua D Stein; Flora Lum; Paul P Lee; William L Rich; Anne L Coleman
Journal:  Ophthalmology       Date:  2014-01-14       Impact factor: 12.079

8.  Longitudinal incidence of adverse outcomes of age-related macular degeneration.

Authors:  Ashley Wysong; Paul P Lee; Frank A Sloan
Journal:  Arch Ophthalmol       Date:  2009-03

9.  Keratoconus in the Medicare population.

Authors:  Sherman W Reeves; Leon B Ellwein; Terry Kim; Roberta Constantine; Paul P Lee
Journal:  Cornea       Date:  2009-01       Impact factor: 2.651

10.  Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data.

Authors:  Aimee Teo Broman; Harry A Quigley; Sheila K West; Joanne Katz; Beatriz Munoz; Karen Bandeen-Roche; James M Tielsch; David S Friedman; Jonathan Crowston; Hugh R Taylor; Rohit Varma; M Cristina Leske; Boel Bengtsson; Anders Heijl; Mingguang He; Paul J Foster
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.